Tài liệu tham khảo |
Loại |
Chi tiết |
11. Pfaller MA, Messer SA, Boyken L et al (2002) In vitro activities of 5-fl uorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob Agents Chemother 46:3518–3521 |
Sách, tạp chí |
|
12. Pfaller MA, Messer SA, Hollis RJ et al (2002) In vitro activities of ravuconazole and voricon- azole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 46:1723–1727 |
Sách, tạp chí |
|
13. Pfaller MA, Diekema DJ, Jones RN, The SENTRY Participants Group et al (2002) Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with blood- stream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 40:852–856 |
Sách, tạp chí |
|
14. Pfaller MA, Messer SA, Boyken L et al (2003) Variation in susceptibility of bloodstream iso- lates of Candida glabrata to fl uconazole according to patient age and geographic location.J Clin Microbiol 41:2176–2179 |
Sách, tạp chí |
Tiêu đề: |
Candida glabrata |
|
15. Pfaller MA, Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus . J Clin Microbiol 42:4419–4431 |
Sách, tạp chí |
Tiêu đề: |
Candida albicans" and "Aspergillus fumigatus |
|
16. Pfaller MA, Diekema DJ (2004) Twelve years of fl uconazole in clinical practice: global trends in species distribution and fl uconazole susceptibility of bloodstream isolates of Candida . Clin Microbiol Infect 10(suppl 1):11–23 |
Sách, tạp chí |
|
17. Pfaller MA, Messer SA, Boyken L et al (2004) Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by sue of an international collection of more than 3,000 clinical isolates. J Clin Microbiol 42:3117–3119 |
Sách, tạp chí |
|
20. Pfaller MA, Messer SA, Boyken L et al (2004) Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol 42:3142–3146 |
Sách, tạp chí |
Tiêu đề: |
Candida glabrata |
|
21. Pfaller MA, Messer SA, Boyken L, Hollis RJ et al (2004) In vitro activities of voriconazole, posaconazole, and fl uconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis 48:201–205 |
Sách, tạp chí |
Tiêu đề: |
Candida" spp. and "Cryptococcus "neoformans |
|
22. Pfaller MA, Boyken L, Hollis RJ et al (2005) In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans , and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by Clinical and Laboratory Standards Institute broth microdilu- tion methods. J Clin Microbiol 43:3807–3810 |
Sách, tạp chí |
Tiêu đề: |
Candida" species, "Cryptococcus neoformans" , and "Aspergillus |
|
23. Pfaller MA, Boyken L, Hollis RJ et al (2005) In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fl uconazole. J Clin Microbiol 43:5425–5427 |
Sách, tạp chí |
|
24. Pfaller MA, Diekema DJ, Rinaldi MG, The Global Antifungal Surveillance Group et al (2005) Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fl uconazole and voriconazole by stan- dardized disk diffusion testing. J Clin Microbiol 43:5848–5859 |
Sách, tạp chí |
|
25. Pfaller MA, Boyken L, Messer SA et al (2005) Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS Global Antifungal Surveillance Program. J Clin Microbiol 43:5208–5213 26. Pfaller MA, Boyken L, Hollis RJ et al (2006) In vitro susceptibilities of Candida spp. to caspo-fungin: four years of global surveillance. J Clin Microbiol 44:760–763 |
Sách, tạp chí |
Tiêu đề: |
Candida" species with results from a central reference laboratory in the ARTEMIS Global Antifungal Surveillance Program. J Clin Microbiol 43:5208–5213 26. Pfaller MA, Boyken L, Hollis RJ et al (2006) In vitro susceptibilities of "Candida |
|
27. Pfaller MA, Diekema DJ, Rex JH et al (2006) Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 44:819–826 |
Sách, tạp chí |
|
28. Pfaller MA, Diekema DJ, Sheehan DJ (2006) Interpretive breakpoints for fl uconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 19:435–447 |
Sách, tạp chí |
|
29. Pfaller MA, Boyken L, Hollis RJ et al (2006) Global surveillance of the in vitro activity of micafungin against Candida : a comparison with caspofungin using Clinical and Laboratory Standards Institute recommended methods. J Clin Microbiol 44:3533–3538 |
Sách, tạp chí |
|
31. Pfaller MA, Diekema DJ, Ghannoum A et al (2009) Wild type MIC distribution and epidemio- logic cutoff values for Aspergillus fumigatus and three triazoles as determined by the CLSI broth microdilution methods. J Clin Microbiol 47:3142–3146 |
Sách, tạp chí |
Tiêu đề: |
Aspergillus fumigatus |
|
38. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG (2007) Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for test- ing amphotericin B, fl ucytosine, and voriconazole against Candida spp. J Clin Microbiol 45:3522–3528 |
Sách, tạp chí |
|
41. Rex JH, Pfaller MA, Galgiani JN et al (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro – in vivo cor- relation data for fl uconazole, itraconazole, and Candida infections. Clin Infect Dis 24:235–247 |
Sách, tạp chí |
|
47. Morrell M, Fraser VJ, Kollef MJ (2005) Delaying empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for mortality.Antimicrob Agents Chemother 49:3640 |
Sách, tạp chí |
|